Korvis, LLC

Korvis, LLC, based in the US, specializes in designing and manufacturing advanced automation solutions for the life sciences and industrial sectors, addressing complex technological challenges. Founded in 2002 in Corvallis, US, Korvis, LLC is focused on advanced design and manufacturing solutions. The company was acquired by Burke Porter Group in August 2016. Rich Carone serves as the CEO.

Ascential Medical & Life Sciences, formerly known as Korvis, specializes in advanced design, development, manufacturing, and automation solutions tailored to the life sciences and industrial markets. The company’s core offerings encompass complex machinery and precision systems, particularly in areas such as microfluidics, optics, precision motion, and automated inspection systems. These products are engineered to address critical challenges in diverse applications, including life sciences, renewable energy, semiconductors, and industrial inkjet printing. Ascential Medical & Life Sciences serves a global clientele, providing tested products ready for immediate deployment to end-users across various regions, with significant market penetration in North America, Europe, and Asia, including notable customers in the transportation and healthcare sectors.

Revenue generation for Ascential Medical & Life Sciences is structured around contract manufacturing and system design services, focusing on B2B transactions with clients in high-demand sectors. The company engages its customers through tailored service agreements, which may include long-term partnerships and support contracts designed to meet specific project requirements. Transactions typically involve the delivery of precision-engineered systems and components, with structured pricing plans that accommodate varying levels of product complexity and customer needs. The firm's offerings, which include specialized solutions in precision motion systems and control, are strategically positioned to capture value in emerging markets and established industries alike, fostering robust revenue streams aligned with customer success and operational efficiency.

The company is focused on developing new products within the automation and precision systems sectors, with launches expected in the next 12-18 months. Ascential Medical & Life Sciences plans to expand into Asian markets, targeting Japan and South Korea by 2024. The recent acquisition by Burke Porter Group in August 2016 will support these growth initiatives, enabling access to additional resources and market expertise.